Innovative, rapid, daytime urine test to diagnose & manage obstructive sleep apnea that will replace overnight sleep lab studies.
Daytime urine biomarker home test allows easy, inexpensive, accurate diagnosis of Obstructive Sleep Apnea, with 100% sensitivity & 96.5% specificity. This is the first & only test to enable ongoing measurement of therapy response (i.e recurring revenue stream). Initially targeting pediatric OSA, where current diagnostic tests are expensive/difficult, it will also be developed to diagnose adult OSA. 1% share of US market equals $76MM in revenue.